PCN56 - Utilization and Cost of Supportive Care Among Patients Receiving Nab-Paclitaxel + Gemcitabine Versus Folfirinox for Metatstatic Pancreatic Cancer

Autor: Patel, M, Parisi, M, Hill, JW, De, AP, Wade, RL
Zdroj: In Value in Health May 2016 19(3):A143-A143
Databáze: ScienceDirect
Externí odkaz: